Innophos (NASDAQ:IPHS) will be announcing its earnings results before the market opens on Thursday, November 1st. Analysts expect the company to announce earnings of $0.83 per share for the quarter.
Innophos (NASDAQ:IPHS) last released its quarterly earnings data on Monday, July 30th. The specialty chemicals company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.10). The firm had revenue of $206.73 million during the quarter, compared to analyst estimates of $213.40 million. Innophos had a net margin of 2.21% and a return on equity of 14.28%. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.57 earnings per share. On average, analysts expect Innophos to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
NASDAQ IPHS opened at $29.89 on Wednesday. The stock has a market capitalization of $601.59 million, a PE ratio of 12.15 and a beta of 0.70. The company has a current ratio of 2.75, a quick ratio of 1.34 and a debt-to-equity ratio of 0.99. Innophos has a 1-year low of $29.18 and a 1-year high of $50.40.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
See Also: Why do earnings reports matter?
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.